Ebba Sohlberg

Company: Karolinska

Job title: Senior Researcher, Project Manager

Seminars:

ADAPT-NK – An Allogeneic Adaptive NK Cell Therapy Platform to Unleash NK Cell Potential 10:30 am

Leveraging adaptive NK cell properties to circumvent inhibitory hurdles of NK cell therapies Utilizing highly cytotoxic ADAPT-NK cells against liquid and solid tumor targets, and in combination with engages Establishment of manufacturing protocol and cell banks to support dose-escalation and expansion of Phase I/II studiesRead more

day: Conference Day One